Rayno Biopharmaceutical Stocks Q1 2014 Performance
Rayno Biopharmaceutical Portfolio 3/31/14 Most of our biotech picks did well in a tough quarter that went through a severe correction in early February and again in late March. Many small and mid-cap momentum stocks were crushed but indices (FBT,IBB) overall held the early February technical...
Large Cap Biopharmaceutical Stocks Will Lead The Way Up
Large Cap Biopharmaceutical Growth Stocks With the MoMo days over the next earnings cycle (Q1,Q2 2014) should give us better clarity on winners for 2014.On the last day of March all of these large caps rallied after a severe one week correction from 3/21-28. Watch the technicals this week for...
Biotechs Weaker As Day Wears On: Counter-trend Green Movers
12:15p EDT 3/26 With NASDAQ down 0.64% and the IBB down 0.6% here are some green stocks: Rayno Life Science Portfolio: AMGN up 0.53%, CPHD up 1.43%, GILD up 0.57%, and REGN up 0.84%. Other Notables on our watch list: CLVS up 4%, CONX up 11%, FMI up 2.7%, KERX up 17%, NSPH up 1.9%, PATH up...
Biotech Stocks Holding At February Lows- Still Up 9% YTD
(See Full Article in Seeking Alpha 3/26) Biopharmaceutical Downdraft 15% From February Highs (IBB$239) Large Cap Biopharmaceutical Stocks Are Core Holdings: ABBV, AMGN, GILD The biotech frenzy of MoMo investing is over so it is time to invest longer term with quality companies. If the sector...
Alert: Broad Biotech Sell-Off of 4-5% ..ALXN, BMRN, GILD, INCY, VRTX, XBI… Update 3/23
Biotech Stocks Will Need To Rebuild Confidence With Momentum Gone Damage on Friday 3/21 was considerable but most indices/ETFs are above 2014 Feb 6 low: FBIOX ($206.4) Up 13.6% YTD, FEB 5 low $196.24 IBB ($246) Up 8.35% YTD, FEB 6 low $237. PBE ($43.33) Up 16.94% YTD, FEB 5 low $40.32 XBI...